EXHIBIT 10.54 FIRST AMENDMENT TO LICENSE AGREEMENT *** Confidential treatment has been requested as to certain portions of this agreement. Such omitted confidential information has been filed separately with the Securities and Exchange Commission...License Agreement • April 1st, 2002 • Senetek PLC /Eng/ • Biological products, (no disgnostic substances)
BACKGROUNDLicense Agreement • April 1st, 2002 • Senetek PLC /Eng/ • Biological products, (no disgnostic substances) • New York
WARRANTSenetek PLC /Eng/ • April 1st, 2002 • Biological products, (no disgnostic substances) • New York
Exhibit 10.53 AMENDMENT TO AGREEMENT *** Confidential treatment has been requested as to certain portions of this agreement. Such omitted confidential information has been filed separately with the Securities and Exchange Commission pursuant to Rule...To Agreement • April 1st, 2002 • Senetek PLC /Eng/ • Biological products, (no disgnostic substances)
Exhibit 10.49 LICENSE AND SUPPLY AGREEMENT ***Confidential treatment has been requested as to certain portions of this agreement. Such omitted confidential information has been filed separately with the Securities and Exchange Commission pursuant to...License and Supply Agreement • April 1st, 2002 • Senetek PLC /Eng/ • Biological products, (no disgnostic substances) • California
EXHIBIT 10.48 DISTRIBUTION AGREEMENT ***Confidential treatment has been requested as to certain portions of this agreement. Such omitted confidential information has been filed separately with the Securities and Exchange Commission pursuant to Rule...Distribution Agreement • April 1st, 2002 • Senetek PLC /Eng/ • Biological products, (no disgnostic substances) • California
WITNESSETH THAT ---------------Production and Marketing Agreement • April 1st, 2002 • Senetek PLC /Eng/ • Biological products, (no disgnostic substances)
